fluoxetine and aspirin

fluoxetine has been researched along with aspirin in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (8.33)18.2507
2000's7 (29.17)29.6817
2010's14 (58.33)24.3611
2020's1 (4.17)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Glen, RC; Lowe, R; Mitchell, JB1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Ekins, S; Williams, AJ; Xu, JJ1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y1
Bazex, J; Durand-Malgouyres, C; Marguery, MC1
Harvey, AT; Lucot, JB; Shad, MU1
Di Perri, T; Gaggelli, E; Laghi Pasini, F; Puccetti, L; Tassini, M; Valensin, G; Vivi, A1
Alsenz, J; Birringer, C; Kuentz, M; Wyttenbach, N1
Alboni, S; Benatti, C; Blom, JM; Brunello, N; Capone, G; Kriwin, P; Mendlewicz, J; Tascedda, F1
Dingwall, K; Douglas, J; Jorgenson, G; Smith, SS1
Bieńkiewicz, M; Gałecka, E; Gałecki, P; Szemraj, J; Zboralski, K1
Gao, F; Jiang, W; Liu, YF; Wang, Y; Yang, F1
Dasgupta, K; Labos, C; Nedjar, H; Rahme, E; Turecki, G1
Andrade, C1
Chen, C; Chen, H; Rui, BB; Wei, W; Xu, TJ; Xu, WP; Yang, JM1
Chen, L; Guan, XT; Shao, F; Wang, W; Xie, X1
Boiani, NF; Borrely, SI; Garcia, VSG; Silva, TT; Tominaga, FK1

Reviews

2 review(s) available for fluoxetine and aspirin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Drug interactions in the treatment of depression in patients with ischemic heart disease.
    The Journal of clinical psychiatry, 2012, Volume: 73, Issue:12

    Topics: Aged; Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Aspirin; Clopidogrel; Comorbidity; Cytochrome P-450 CYP2C19; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Early Diagnosis; Fluoxetine; Fluvoxamine; Gastrointestinal Hemorrhage; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk Factors; Selective Serotonin Reuptake Inhibitors; Ticlopidine

2012

Other Studies

22 other study(ies) available for fluoxetine and aspirin

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
    Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16

    Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone

2016
[Aquagenic pruritus (A.P.)].
    Allergie et immunologie, 1990, Volume: 22, Issue:7

    Topics: Acetylcholine; Age Factors; Aspirin; Bicarbonates; Fibrinolysis; Fluoxetine; Globulins; Histamine; Humans; Mast Cells; Pruritus; Sodium; Sodium Bicarbonate; Ultraviolet Rays; Water

1990
A possible pharmacokinetic interaction between fluoxetine and acetylsalicylic acid.
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:12

    Topics: Adult; Arthralgia; Aspirin; Depressive Disorder; Drug Hypersensitivity; Drug Interactions; Fluoxetine; Humans; Male; Urticaria

1997
Effects of fluoxetine treatment on carbohydrate metabolism in human blood platelets: a 1H-NMR study.
    Archives of biochemistry and biophysics, 2002, Aug-01, Volume: 404, Issue:1

    Topics: Aspirin; Blood Glucose; Blood Platelets; Carbohydrates; Fluoxetine; Humans; In Vitro Techniques; Lactic Acid; Magnetic Resonance Spectroscopy; Platelet Aggregation; Selective Serotonin Reuptake Inhibitors; Serotonin

2002
Drug-excipient compatibility testing using a high-throughput approach and statistical design.
    Pharmaceutical development and technology, 2005, Volume: 10, Issue:4

    Topics: Aspirin; Chromatography, High Pressure Liquid; Data Interpretation, Statistical; Drug Compounding; Drug Incompatibility; Drug Stability; Drug Storage; Excipients; Fluoxetine; Hot Temperature; Humidity; Pharmaceutical Preparations; Time Factors

2005
Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression.
    International clinical psychopharmacology, 2006, Volume: 21, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Antidepressive Agents; Aspirin; Depression; Drug Synergism; Escape Reaction; Fluoxetine; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Time Factors

2006
Associations between the use of common medications and sleep architecture in patients with untreated obstructive sleep apnea.
    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2006, Apr-15, Volume: 2, Issue:2

    Topics: Adrenergic beta-Antagonists; Amitriptyline; Antidepressive Agents; Aspirin; Drug Therapy; Female; Fluoxetine; Health Status; Humans; Male; Middle Aged; Paroxetine; Polysomnography; Retrospective Studies; Sleep Apnea, Obstructive; Sleep, REM; Treatment Refusal

2006
Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients.
    Human psychopharmacology, 2009, Volume: 24, Issue:4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Second-Generation; Antioxidants; Aspirin; Depressive Disorder, Major; Drug Therapy, Combination; Fluoxetine; Humans; Lipid Peroxidation; Oxidative Stress; Psychiatric Status Rating Scales

2009
Acetylsalicylic acid as an augmentation agent in fluoxetine treatment resistant depressive rats.
    Neuroscience letters, 2011, Jul-20, Volume: 499, Issue:2

    Topics: Animals; Antidepressive Agents; Aspirin; Depression; Drug Therapy, Combination; Fluoxetine; Hippocampus; Male; Rats; Rats, Sprague-Dawley; Treatment Outcome

2011
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2011, Nov-08, Volume: 183, Issue:16

    Topics: Adrenal Cortex Hormones; Age Factors; Aged; Anemia; Angioplasty; Anticoagulants; Antihypertensive Agents; Aspirin; Canada; Citalopram; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Heart Failure; Hemorrhage; Humans; Hypoglycemic Agents; Male; Middle Aged; Myocardial Infarction; Neoplasms; Paroxetine; Peptic Ulcer; Platelet Aggregation Inhibitors; Renal Insufficiency; Retrospective Studies; Risk; Risk Factors; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Ticlopidine

2011
Acetylsalicylic acid enhances the anti-inflammatory effect of fluoxetine through inhibition of NF-κB, p38-MAPK and ERK1/2 activation in lipopolysaccharide-induced BV-2 microglia cells.
    Neuroscience, 2014, Sep-05, Volume: 275

    Topics: Animals; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Aspirin; Blotting, Western; Cell Line; Cell Survival; Enzyme-Linked Immunosorbent Assay; Fluoxetine; Immunohistochemistry; Inflammation; Lipopolysaccharides; MAP Kinase Signaling System; Mice; Microglia; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Signal Transduction

2014
Effects of aspirin on immobile behavior and endocrine and immune changes in the forced swimming test: comparison to fluoxetine and imipramine.
    Pharmacology, biochemistry, and behavior, 2014, Volume: 124

    Topics: Animals; Antidepressive Agents; Aspirin; Behavior, Animal; Corticosterone; Endocrine Glands; Fluoxetine; Imipramine; Immune System; Interleukin-6; Male; Rats; Rats, Sprague-Dawley; Swimming; Tumor Necrosis Factor-alpha

2014
Acute and chronic ecotoxicological effects of pharmaceuticals and their mixtures in Daphnia similis.
    Chemosphere, 2022, Volume: 309, Issue:Pt 1

    Topics: Animals; Anti-Bacterial Agents; Aspirin; Ciprofloxacin; Daphnia; Fluoxetine; Hypoglycemic Agents; Metformin; Pharmaceutical Preparations; Water; Water Pollutants, Chemical

2022